Stocks to Watch Monday: American Airlines, USA Rare Earth, RevMed -- WSJ

Dow Jones01-26

By WSJ Staff

American Airlines $(AAL)$: Flight cancellations and delays mounted over the weekend after a winter storm snarled the central and eastern U.S. American Airlines scrapped more than 1,500 flights, nearly half of its schedule. Shares fell around 1% in premarket trading.

USA Rare Earth (USAR): The Trump administration plans to inject $1.6 billion into the rare-earth miner in return for a 10% stake, according to media reports. Shares soared in premarket trading. Other rare-earth companies, such as MP Materials (MP), also rallied.

Ryanair (IE:RYA, RYAAY): The Irish low-cost carrier raised its annual guidance, citing strong demand and earlier-than-expected Boeing $(BA)$ deliveries. However, it posted a sharp drop in quarterly profit. Shares fell around 1.5%.

Revolution Medicines (RVMD): Drugmaker Merck $(MRK)$ is no longer in discussions to buy the cancer-drug biotech because of an inability to agree on a price. RevMed's shares slid by one-quarter premarket.

EssilorLuxottica (FR:EL): The Ray-Ban maker and Meta Platforms (META) face a lawsuit alleging infringement of patents for smartglasses technologies. Solos Technology is seeking billions of dollars in damages. EssilorLuxottica shares fell 1% in Paris.

Enphase Energy (ENPH): The solar-energy company plans to cut about 6% of its staff. The end of a federal tax credit has sapped demand for residential solar panels.

Sarepta Therapeutics (SRP): The gene-therapy maker said late Friday it will present results from a study of its Elevidys muscular dystrophy treatment this morning. Shares jumped 10% premarket. The stock tanked last year after fatal liver failure cases in Elevidys patients.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

January 26, 2026 04:55 ET (09:55 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment